pubmed-article:526559 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0220806 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0017110 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0018546 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0577559 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0596801 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C1510438 | lld:lifeskim |
pubmed-article:526559 | lifeskim:mentions | umls-concept:C0598827 | lld:lifeskim |
pubmed-article:526559 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:526559 | pubmed:dateCreated | 1980-4-26 | lld:pubmed |
pubmed-article:526559 | pubmed:abstractText | A new gas chromatographic mass spectrometric chemical ionization assay for haloperidol with selectedion monitoring is presented which provides for better combined selectivity and sensitivity than previous assays. Levels of haloperidol in 2 ml of human plasma were reproducibly measured down to subnanogram levels. Both methane and methane--ammonia chemical ionization spectra are presented for haloperidol and the internal standard trifluperidol. | lld:pubmed |
pubmed-article:526559 | pubmed:language | eng | lld:pubmed |
pubmed-article:526559 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:526559 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:526559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:526559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:526559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:526559 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:526559 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:526559 | pubmed:month | Oct | lld:pubmed |
pubmed-article:526559 | pubmed:issn | 0306-042X | lld:pubmed |
pubmed-article:526559 | pubmed:author | pubmed-author:HornbeckC LCL | lld:pubmed |
pubmed-article:526559 | pubmed:author | pubmed-author:GriffithsJ... | lld:pubmed |
pubmed-article:526559 | pubmed:author | pubmed-author:FaulknerM AMA | lld:pubmed |
pubmed-article:526559 | pubmed:author | pubmed-author:NeborskyR JRJ | lld:pubmed |
pubmed-article:526559 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:526559 | pubmed:volume | 6 | lld:pubmed |
pubmed-article:526559 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:526559 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:526559 | pubmed:pagination | 427-30 | lld:pubmed |
pubmed-article:526559 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-H... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-A... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-A... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-M... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-M... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-P... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-A... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-H... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-T... | lld:pubmed |
pubmed-article:526559 | pubmed:meshHeading | pubmed-meshheading:526559-G... | lld:pubmed |
pubmed-article:526559 | pubmed:year | 1979 | lld:pubmed |
pubmed-article:526559 | pubmed:articleTitle | A gas chromatographic mass spectrometric chemical ionization assay for haloperidol with selected ion monitoring. | lld:pubmed |
pubmed-article:526559 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:526559 | pubmed:publicationType | Comparative Study | lld:pubmed |